Your browser doesn't support javascript.
loading
Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.
Kaderbhai, Courèche-Guillaume; Richard, Corentin; Fumet, Jean David; Aarnink, Anne; Ortiz-Cuaran, Sandra; Pérol, Maurice; Foucher, Pascal; Coudert, Bruno; Favier, Laure; Lagrange, Aurélie; Limagne, Emeric; Boidot, Romain; Ladoire, Sylvain; Poudenx, Michel; Ilie, Marius; Hofman, Paul; Saintigny, Pierre; Ghiringhelli, François.
Afiliación
  • Kaderbhai CG; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Richard C; Plateform Transfer in Biological Oncology, Dijon, France.
  • Fumet JD; Plateform Transfer in Biological Oncology, Dijon, France.
  • Aarnink A; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Ortiz-Cuaran S; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Pérol M; Plateform Transfer in Biological Oncology, Dijon, France.
  • Foucher P; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Coudert B; Department of Medical Oncology, Center Leon Berard, Lyon, France.
  • Favier L; Department of Medical Oncology, Center Leon Berard, Lyon, France.
  • Lagrange A; Department of Thoracic Oncology CHU, Dijon, France.
  • Limagne E; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Boidot R; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Ladoire S; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Poudenx M; Plateform Transfer in Biological Oncology, Dijon, France.
  • Ilie M; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Hofman P; Plateform Transfer in Biological Oncology, Dijon, France.
  • Saintigny P; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Ghiringhelli F; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Oncoimmunology ; 6(9): e1339856, 2017.
Article en En | MEDLINE | ID: mdl-28932641

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Año: 2017 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Año: 2017 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos